SPRINT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sprint Bioscience AB

Watchlist Manager

Watchlist

Price: 3.59 SEK 1.41% Market Closed

Market Cap: kr378.8m

S	Sprint Bioscience AB STO:SPRINT	SE
	Siloam International Hospitals Tbk PT IDX:SILO	ID
E	Experian PLC OTC:EXPGF	IE
	M P Evans Group PLC F:NYP	UK
L	L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA OTC:AIQUF	FR
	Orrstown Financial Services Inc NASDAQ:ORRF	US
	Montana Aerospace AG OTC:MTASF	CH
N	Nakayo Inc TSE:6715	JP
B	Bridgestone Corp SWB:BGT	JP

Profitability Summary

Sprint Bioscience AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Negative 3Y Average Gross Margin

-1.386%

Gross Margin is Increasing

-15.956% > 92%

Exceptional Operating Margin

58%

Negative 3Y Average Operating Margin

-7.813%

Operating Margin is Increasing

-85.811% > 58%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-7.772%

Net Margin is Increasing

-85.364% > 55%

Exceptional Free Cash Flow Margin

50%

Negative 3Y Average Free Cash Flow Margin

-6.544%

Free Cash Flow Margin is Increasing

-71.910% > 50%

Exceptional ROE

143%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-120%

ROIC is Increasing

-1.142% > 1.140%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.